Calpeptin是一种强效的细胞透过性钙蛋白酶抑制剂,ID50 分别为 52 nM、34 nM、138 nM 和 40 nM,针对猪红细胞的 Calpain I、猪肾脏的 Calpain II、Papainb 及人血小板的 Calpain I。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Cysteine Protease ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Z-FA-FMK | ✔ | 99%+ | |||||||||||||||||
| Leupeptin hemisulfate | ✔ | 97% | |||||||||||||||||
| PMSF | ✔ | 95% | |||||||||||||||||
| PD 151746 |
+
μ-Calpain, IC50: 260 nM m-calpain, IC50: 5.33 μM |
95% | |||||||||||||||||
| Odanacatib |
++++
Cathepsin K (human), IC50: 0.2 nM Cathepsin K (rabbit), IC50: 1 nM |
99%+ | |||||||||||||||||
| E-64 |
+++
Cysteine protease, IC50: 9 nM |
99%+ | |||||||||||||||||
| E 64c | ✔ | 95% | |||||||||||||||||
| E-64d | ✔ | 99%+ | |||||||||||||||||
| MG-101 | ✔ | 98%+ | |||||||||||||||||
| Calpeptin |
++
Calpain I (porcine erythrocytes), ID50: 52 nM Calpain II (porcine kidney), ID50: 40 nM |
98%+ | |||||||||||||||||
| Cathepsin inhibitor 1 |
+++
Cathepsin L, pIC50: 7.9 Cathepsin L2, pIC50: 5.5 |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Calpain is a Ca2+-mediated cytosolic cyctein protease existed in various cells. Calpeptin is a potent calpain inhibitor with ID50 values of 52 nM, 34 nM, 138 nM, and 40 nM for Calpain I (porcine erythrocytes), Calpain II (porcine kidney), Papain, and Calpain I (human platelets), respectively. In platelets stimulated by A23187, 66% of ABP and 69% of P235 remained undegraded in the presence of 10μg/mL calpeptin, in comparison to 26% of ABP and 40% of P235 remained without calpeptin. The activity of intrinsic calpain in platelets was completely abolished by the treatment of 100μg/mL calpeptin[4]. Calpeptin at the concentration of 34nM reduced calpain activity by 44% in the homogenate of proliferating PC12 cells. When PCI2 cells were incubated with NGF and 36μM calpeptin for 17h, the probabilities for a PCI2 cell to extend a given maximal neurite length were increased as compared to non-calpeptin-treated cells[5]. In a murine model of middle cerebral artery occlusion, the intra-cerebroventricle injection of calpeptin (50μg dissolved in 5μL DMSO) before the occlusion resulted in a significant reduction of neuronal apoptosis in hippocampal CA1 sector, as compared to DMSO-treated animals, via the inhibition of caspase-3 expression[6]. |
| Concentration | Treated Time | Description | References | |
| Vero E6 cells | 50 µM | 12 hours to 24 hours | To study the effect of Calpeptin on the cleavage of SARS-CoV-2 viral proteins, it was found that Calpeptin treatment significantly reduced the cleavage products at N19, S260, and S637 sites. | Nat Commun. 2021 Sep 21;12(1):5553. |
| N2a cells | 40 µM | 24 hours | To test the effect of Calpeptin on NF protein degradation in N2a cells, results showed that Calpeptin significantly increased the levels of all three NF proteins. | Autophagy. 2023 Apr;19(4):1277-1292. |
| Rat primary cortical neurons | 50 µM | 24 hours | To investigate the effect of Calpeptin on okadaic acid-induced cleavage of DLP1 and spectrin. Results showed that Calpeptin completely inhibited the okadaic acid-induced cleavage of DLP1 and spectrin. | Aging Cell. 2019 Jun;18(3):e12912. |
| HEK293 cells | 30 µg/ml | 3 hours | To study the effect of Calpeptin on ABCA1 protein levels, results showed that Calpeptin treatment significantly increased ABCA1 protein levels. | J Clin Invest. 2003 Jan;111(1):99-107. |
| Mouse peritoneal macrophages | 20 µg/ml | 3 hours | To study the effect of Calpeptin on ABCA1 protein levels in mouse peritoneal macrophages, results showed that Calpeptin treatment significantly increased ABCA1 protein levels. | J Clin Invest. 2003 Jan;111(1):99-107. |
| Mouse primary hepatocytes | 15 µg/ml | 3 hours | To study the effect of Calpeptin on ABCA1 protein levels in mouse primary hepatocytes, results showed that Calpeptin treatment significantly increased ABCA1 protein levels. | J Clin Invest. 2003 Jan;111(1):99-107. |
| Bovine aortic endothelial cells | 10 µM | 30 minutes | To investigate the effect of Calpeptin on VEGF-induced NO• production in endothelial cells, results showed that Calpeptin significantly inhibited VEGF-induced NO• production. | Circ Res. 2009 Jan 2;104(1):50-9. |
| Intestinal epithelial cells (IECs) | 1 μg/ml | 4 hours | To study the effect of Calpeptin on caspase 3 activation in MDP-stimulated IECs, results showed that Calpeptin treatment prevented caspase 3 activation. | J Clin Invest. 2015 Mar 2;125(3):1098-110. |
| Rat hippocampal neurons | 50 µM | 4 hours | To investigate the effect of Calpeptin on AMPA-induced down-regulation of TARPγ8 and GluA1 protein levels, results showed that Calpeptin significantly blocked the AMPA-induced down-regulation of TARPγ8 and GluA1. | Acta Pharmacol Sin. 2016 Mar;37(3):303-11. |
| Rat primary cortical neurons | 50 µM | 4 hours | To investigate the effect of Calpeptin on glutamate-induced cleavage of DLP1 and spectrin. Results showed that Calpeptin significantly inhibited the glutamate-induced cleavage of DLP1 and spectrin. | Aging Cell. 2019 Jun;18(3):e12912. |
| Primary cortical neurons from CRND8 APP transgenic mice | 50 µM | 4 hours | To investigate the effect of Calpeptin on DLP1 and spectrin cleavage in primary cortical neurons from CRND8 APP transgenic mice. Results showed that Calpeptin inhibited the cleavage of DLP1 and spectrin in CRND8 mouse neurons. | Aging Cell. 2019 Jun;18(3):e12912. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | C57BL/6J mice | FemOral vein injection | 20 mg/kg | Single injection, analyzed after 4 hours | To study the effect of ApoA-I injection on ABCA1 protein levels in mouse liver and peritoneal macrophages, results showed that ApoA-I injection significantly increased ABCA1 protein levels. | J Clin Invest. 2003 Jan;111(1):99-107. |
| Mice | DSS-induced colitis model | Intraperitoneal injection | 5 mg/kg | Daily for 5 days | To study the effect of Calpeptin on DSS-induced colitis in mice, results showed that Calpeptin treatment reduced weight loss and improved architectural distortion and epithelial cell death. | J Clin Invest. 2015 Mar 2;125(3):1098-110. |
| Zebrafish | Transgenic GFP-Lc3 zebrafish embryos | Embryo water | 50 μM | 24 hours | Calpeptin significantly induced the formation of Lc3-positive puncta and colocalization with autolysosomes, and upregulated the conversion of endogenous Lc3. | Autophagy. 2009 May;5(4):520-6 |
| Mice | SMA mouse models | Subcutaneous injection | 6 μg/g | Once daily until postnatal day 8 | To study the effect of Calpeptin on survival and motor function in SMA mice, results showed that Calpeptin treatment increased SMN protein levels and improved motor function | Cell Death Dis. 2020 Jun 25;11(6):487 |
| Dose | Mice: 10 mg/kg[3] (i.p.) |
| Administration | i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.76mL 0.55mL 0.28mL |
13.79mL 2.76mL 1.38mL |
27.59mL 5.52mL 2.76mL |
|
| CAS号 | 117591-20-5 |
| 分子式 | C20H30N2O4 |
| 分子量 | 362.46 |
| SMILES Code | O=C(OCC1=CC=CC=C1)N[C@H](C(N[C@H](C=O)CCCC)=O)CC(C)C |
| MDL No. | MFCD00155623 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | PGGUOGKHUUUWAF-ROUUACIJSA-N |
| Pubchem ID | 73364 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(289.68 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1